HOME >> MEDICINE >> NEWS
Vaccine may complement conventional treatment for chronic leukaemia

A vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia (CML), suggest early results of a trial published in this week's issue of THE LANCET.

CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa. Treatment with imatinib can lead to complete cytogenetic remission, where no Philadelphia chromosomes are detected during cell division. However, a complete molecular response, where there is no evidence of the protein produced by the Philadelphia chromosomes, is rare.

Monica Bocchia (University of Siena, Italy) and colleagues tested whether a vaccine that targets a protein derived from the Philadelphia chromosome could help to eradicate the disease in patients. The investigators enrolled 16 individuals (10 patients on imatinib and 6 on interferon) with stable, but detectable disease into the trial. Patients were given one dose (six injections) of the protein vaccine every 2 weeks while they continued their conventional treatment. Patients were assessed before vaccination and after three and six doses for evidence of the disease.

Nine patients on imatinib showed progressive reduction of their residual disease after three and six doses of the vaccine with five patients reaching complete cytogenetic remission. Three of the five patients also obtained undetectable disease at a molecular level. Of the six patients on interferon alfa, five showed a reduction of their stable disease during vaccinations, with two reaching complete cytogenetic remission.

Dr Bocchia comments: "Our preliminary data suggest that the addition of this vaccine to patients treated with conventional treatment might favour further
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
17-Feb-2005


Page: 1 2

Related medicine news :

1. Vaccine against childhood pneumonia shows promise
2. Vaccine preparedness, or not
3. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
4. Vaccine reduces racial disparity in incidence of childhood pneumonia and meningitis
5. Vaccine nips breast cancer in the bud
6. Vaccine shows promise for kidney cancer
7. Vaccine development against influenza A (h5n1) virus should be made a priority
8. Vaccines against fatal African cattle fever
9. Vaccine development sparks debate on changes to cervical cancer screening guidelines
10. Vaccine shortage study exposes nations patchwork system
11. Vaccines prevent cancers of the liver and cervix

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free Know ... which is available for Apple and Android , seeks to streamline ... , “When COVID-19 first hit, there was so much that we didn’t know,” says ...
(Date:8/5/2020)... ... 2020 , ... MemoryCare.com , a comprehensive resource for ... Care Facilities in Austin, Texas. The guide identifies 14 memory care communities based ... the Alzheimer’s Association , 5.6 million people aged 65 and older are ...
(Date:8/3/2020)... Ariz. (PRWEB) , ... August 03, 2020 , ... ... announced today the launch of its newest product, CoverageCoach. The site provides a ... compare, and purchase insurance products. The company sees CoverageCoach as an important expansion ...
(Date:7/31/2020)... , ... July 31, 2020 , ... ... Meridian Clinical Research’s internal medicine site in Savannah, GA. Visitors included ... OWS. , In May, the federal government announced the OWS program to accelerate ...
(Date:7/31/2020)... Va. (PRWEB) , ... July 31, 2020 , ... ... CEO Steven C. Anderson issued the following statement today regarding the nation’s ongoing ... pharmacies present patients and the nation with an efficient, effective and essential component ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... As one of the most prominent and popular ... Missouri City, TX, with a wide range of professional dental services for many years. ... facility that is not far from the previous clinic location. Dr. Simone Ellis’s modern, ...
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, the ... announce the addition of Moderna to its growing customer roster. , TrialScope customers ... for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are ...
(Date:7/18/2020)... ... , ... A Perspective essay published in Psychosomatics: ... among psychiatrists and other clinicians can affect patient-clinician communication and diminish the quality ... authored by researchers at The Fenway Institute and Massachusetts General Hospital and adds ...
Breaking Medicine Technology:
Cached News: